Ligand validation:8ACY

RBF: RIBOFLAVIN

RBF is a Ligand Of Interest in 8ACY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8ACY_RBF_B_502	0%	65%	0.739	0.681	0.6	0.72	-	2	4	0	100%	1
8AD0_RBF_B_502	4%	66%	0.432	0.812	0.57	0.71	-	2	2	0	100%	1
8ACW_RBF_B_502	1%	66%	0.579	0.706	0.57	0.7	-	1	0	0	100%	1
7QF2_RBF_AAA_201	100%	54%	0.047	0.991	0.96	0.8	3	1	0	0	100%	1
4IIL_RBF_A_401	99%	36%	0.047	0.987	1.37	1.22	4	5	0	0	100%	1
7QF4_RBF_AAA_201	99%	55%	0.054	0.986	0.98	0.74	1	-	0	0	100%	1
4KUK_RBF_A_201	97%	34%	0.07	0.986	1.36	1.37	4	8	0	0	100%	1
3A35_RBF_A_191	95%	15%	0.069	0.974	2.33	1.65	8	9	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.